Are you Dr. Chang?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 89 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
18350 Roscoe Blvd
Suite 101
Northridge, CA 91325Phone+1 818-349-8300Fax+1 818-349-2214
Summary
- Dr. Andrew Chang, MD is a board certified ophthalmologist in Northridge, California. He is currently licensed to practice medicine in California. He is affiliated with Northridge Hospital Medical Center, Olive View-UCLA Medical Center, and Huntington Health.
Education & Training
UCLA David Geffen School of Medicine/UCLA Medical Center/UCLA Stein and Doheny Eye InstitutesResidency, Ophthalmology, 1987 - 1990- UCLA David Geffen School of Medicine/UCLA Medical CenterInternship, Internal Medicine, 1986 - 1987
David Geffen School of Medicine at UCLAClass of 1986
Certifications & Licensure
CA State Medical License 1987 - 2025- American Board of Ophthalmology Ophthalmology
Awards, Honors, & Recognition
- Super Doctor SuperDoctors.com
- Fellow (FAAO) American Academy of Ophthalmology
Publications & Presentations
PubMed
- Infographic: study design of the BALATON and COMINO phase 3 randomised trials of faricimab in patients with retinal vein occlusion.Andrew Chang, Aachal Kotecha, Faiz Kermani, Insaf Saffar
Eye. 2024-08-01 - 8 citationsLong-term Anti-Vascular Endothelial Growth Factor Treatment for Neovascular Age-Related Macular Degeneration: The LATAR Study: Report 1: Ten-Year, Real-World Outcomes.Kimberly Spooner, Samantha Fraser-Bell, Thomas Hong, Long Phan, James Wong
Ophthalmology. Retina. 2021-06-01 - Re: Switching therapy from bevacizumab to aflibercept for the management of persistent diabetic macular edema.Bobak Bahrami, Thomas Hong, Andrew Chang
Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie. 2017-07-01
Press Mentions
- Two-Year Results of the Phase 3 Randomized Controlled Study of Abicipar in Neovascular Age‐Related Macular DegenerationNovember 19th, 2020
American BriVision Highlights Results from Vitargus® First-in-Human Clinical TrialOctober 15th, 2019
American BriVision Announces Vitargus® Presentation at Upcoming AAO 2019 Annual MeetingOctober 10th, 2019
Professional Memberships
- Fellow
